About Worldwide  |     FAQs    |    Careers    |        Media Center  |    Taj Pharmaceuticals  World   |    TAJ Group
      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

taj natures

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Sennoside A + B_left






























 

 




FORMULA C42H36CaO20

Sennoside A + B


CAS NO. 81-27-6 (Sennoside A)

128-57-4 (Sennoside B)

517-43-1, 52730-37-7 (Calcium Salt)

EINECS NO. 201-339-9 (Sennoside A)

204-895-0 (Sennoside B)

FORMULA C42H36CaO20

MOL WT. 900.81

TOXICITY

SYNONYMS Sennoside A and B Calcium salts;
5,5'-Bis(beta-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo[9,9'- bianthracene]-2,2'-dicarboxylic acid calcium salt
DERIVATION

CLASSIFICATION

PHYSICAL AND CHEMICAL PROPERTIES
PHYSICAL STATE pale brownish hygroscopic powder
MELTING POINT
BOILING POINT

SPECIFIC GRAVITY

SOLUBILITY IN WATER Soluble
pH 6.3 - 7.3
VAPOR DENSITY

AUTOIGNITION

NFPA RATINGS
Health: 2 Flammability: 0 Reactivity: 0

STABILITY

Stable under ordinary conditions. Hygroscopic.

API- Taj Pharmaceuticals Ltd . All rights reserved

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

      Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.